Table of Contents
|
|
|
|
Preface |
vii |
|
Acknowledgments |
ix |
SECTION I |
FUNDAMENTAL
PRINCIPLES OF PHARMACOLOGY |
1 |
1 |
Drug-Receptor Interactions |
3 |
2 |
Pharmacodynamics |
7 |
3 |
Pharmacokinetics |
11 |
4 |
Drug Metabolism |
15 |
5 |
Drug Toxicity |
19 |
|
Answers to Section 1 |
22 |
SECTION II |
PRINCIPLES OF
NEUROPHARMACOLOGY |
29 |
6 |
Principles of Cellular Excitability and
Electrochemical Transmission |
31 |
7 |
Principles of Nervous System Physiology and
Pharmacology |
35 |
8 |
Cholinergic Pharmacology |
39 |
9 |
Adrenergic Pharmacology |
43 |
10 |
Local Anesthetic Pharmacology |
47 |
11 |
Pharmacology of GABAergic
and Glutamatergic
Neurotransmission |
51 |
12 |
Pharmacology of Dopaminergic
Neurotransmission |
55 |
13 |
Pharmacology of Serotonergic
and Central Adrenergic Neurotransmission |
59 |
14 |
Pharmacology of Abnormal Electrical
Neurotransmission in the Central Nervous System |
63 |
15 |
General Anesthetic Pharmacology |
67 |
16 |
Pharmacology of Analgesia |
71 |
17 |
Pharmacology of Drug Dependence and Addiction |
75 |
|
Answers to Section 2 |
79 |
SECTION III |
PRINCIPLES OF
CARDIOVASCULAR PHARMACOLOGY |
95 |
18 |
Pharmacology of Cardiac Rhythm |
97 |
19 |
Pharmacology of Cardiac Contractility |
101 |
20 |
Pharmacology of Volume Regulation |
105 |
21 |
Pharmacology of Vascular Tone |
109 |
22 |
Pharmacology of Hemostasis
and Thrombosis |
113 |
23 |
Pharmacology of Cholesterol and Lipoprotein
Metabolism |
119 |
24 |
Integrative Cardiovascular Pharmacology:
Hypertension, Ischemic Heart Disease, and Heart Failure |
125 |
|
Answers to Section 3 |
130 |
SECTION IV |
PRINCIPLES OF
ENDOCRINE PHARMACOLOGY |
141 |
25 |
Pharmacology of the Hypothalamus and Pituitary
Gland |
143 |
26 |
Pharmacology of the Thyroid Gland |
147 |
27 |
Pharmacology of the Adrenal Cortex |
151 |
28 |
Pharmacology of Reproduction |
155 |
29 |
Pharmacology of the Endocrine Pancreas |
159 |
30 |
Pharmacology of Bone Mineral Homeostasis |
163 |
|
Answers to Section 4 |
167 |
SECTION V |
PRINCIPLES OF
CHEMOTHERAPY |
175 |
31 |
Principles of Antimicrobial and Antineoplastic
Pharmacology |
177 |
32 |
Pharmacology of Bacterial Infections: DNA
Replication, Transcription, and Translation |
181 |
33 |
Pharmacology of Bacterial Infections: Cell Wall
Synthesis |
185 |
34 |
Pharmacology of Fungal Infections |
189 |
35 |
Pharmacology of Parasitic Infections |
193 |
36 |
Pharmacology of Viral Infections |
197 |
37 |
Pharmacology of Cancer: Genome Synthesis,
Stability, and Maintenance |
201 |
38 |
Pharmacology of Cancer: Signal Transduction |
205 |
39 |
Principles of Combination Chemotherapy |
209 |
|
Answers to Section 5 |
212 |
SECTION VI |
PRINCIPLES OF
INFLAMMATION AND IMMUNE PHARMACOLOGY |
221 |
40 |
Principles of Inflammation and the Immune System |
223 |
41 |
Pharmacology of Eicosanoids |
227 |
42 |
Histamine Pharmacology |
233 |
43 |
Pharmacology of Hematopoiesis
and Irnmunomodulation |
237 |
44 |
Pharmacology of Immunosuppression |
241 |
45 |
Integrative Inflammation Pharmacology: Peptic
Ulcer Disease |
245 |
46 |
Integrative Inflammation Pharmacology: Asthma |
249 |
47 |
Integrative Inflammation Pharmacology: Gout |
253 |
|
Answers to Section 6 |
256 |
SECTION VII |
FUNDAMENTALS OF
DRUG DEVELOPMENT AND REGULATION |
265 |
48 |
Drug Discovery and Preclinical Development |
267 |
49 |
Clinical Drug Evaluation and Regulatory Approval |
271 |
50 |
Systematic Detection of Adverse Events in
Marketed Drugs |
275 |
|
Answers to Section 7 |
278 |
SECTION VIII |
POISONING BY DRUGS
AND ENVIRONMENTAL TOXINS |
281 |
51 |
Poisoning by Drugs and Environmental Toxins |
283 |
|
Answers to Section 8 |
285 |
SECTION IX |
FRONTIERS IN
PHARMACOLOGY |
287 |
52 |
Pharmacogenomics |
289 |
53 |
Protein-Based Therapies |
293 |
54 |
Drug Delivery Modalities |
297 |
|
Answers to Section 9 |
300 |
|
|
|